Kracalik & Basavaraju: "Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: follow-up surveillance study"; SEE highlights!

by Paul Alexander

I will embed the paragraphs or lines that IMO you should pay attention to for the authors tried to write the interpretation and conclusion in a downplayed manner but the results are quite troubling

I applaud the study but the authors are trying to whitewash troubling findings. I would argue these findings are devastating. Very serious for we are looking at people aged 12-29 years old, young persons here who seem to have long-term adverse effects due to myocarditis post vaccine. Myocarditis is not ‘mild’ and the heart scarring (myocardial scarring) can be catastrophic. Is it just me or do you also see serious problems in this study as to the harmful effects of the vaccine as it relates to myocarditis? The authors’ conclusions surely IMO do not match the presented data and evidence, once you ‘look under the hood’. We are looking at young persons 90 days out since onset of myocarditis, and the findings are very troubling (at least 90 days post myocarditis onset).

Just look at how the authors concluded and you tell me, does the included findings match this Polyanna ‘puffy and pink’ interpretation by the authors? To me, definitely not!

Authors: “After at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination, most individuals in our cohort were considered recovered by health-care providers, and quality of life measures were comparable to those in pre-pandemic and early pandemic populations of a similar age.”

For example, consider this statement by the authors:

 

“In summary, after at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination, 81% of patients were considered recovered by their health-care provider”. Does that sound like a good thing to you? 81% recovered, so what about the rest? What about the medications placed on and the scaring etc.? One had to go on ECMO.

SOURCE:

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00244-9/fulltext

In this follow-up surveillance study, we included US patients who were aged 12–29 years at the time of mRNA COVID-19 vaccination and for whom the time to myocarditis symptom onset was more than 90 days since vaccination and a VAERS report was filed between Jan 12, to Nov 5, 2021.

see this key Figure 1 and look at the disposition of the patients:

Notes, see highlighted areas and tables of the areas I suggest you focus on:

1)

2)

3)

4)

  1. Key is children are absent from school and state linked to myocarditis

6)

7)

8)

9)

10)

11)

12)

13)

14)

15)

16)

17)

18)

19)

20)

21)

22)

23)

24)